Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'leu31 pro34 neuropeptide y human rat'

Search results for: 'leu31 pro34 neuropeptide y human rat'

Items 11-20 of 67

Page
per page
  1. Varespladib (LY315920)
    A4356 Varespladib (LY315920)
    Target: Phospholipases
    Summary: HnsPLA inhibitor,potent and selective
  2. Ki16425
    A1987 Ki16425
     4 Citation
    Target: LPA Receptors
    Summary: LPA receptor antagonist
      ≥23.75 mg/mL
  3. Paclitaxel (Taxol)
    A4393 Paclitaxel (Taxol)
     4 Citation
    Target: Microtubules/Tubulins
    Summary: Antineoplastic agent
      ≥85.6 mg/mL
  4. WY-14643 (Pirinixic Acid)
    A4305 WY-14643 (Pirinixic Acid)
     1 Citation
    Target: PPAR
    Summary: PPARα agonist,selective and highly potent
      insoluble in H2O; ≥16.2 mg/mL
  5. GW9662
    A4300 GW9662
     1 Citation
    Summary: PPARγ antagonist
      insoluble in H2O; ≥13.75 mg/mL
  6. QNZ (EVP4593)
    A4217 QNZ (EVP4593)
     2 Citation
    Summary: Potent NF-κB inhibitor
  7. Aprepitant
    A1684 Aprepitant
    Target: Substance P/NK1 Receptor
    Summary: Substance P (SP) inhibitor
      ≥26.72 mg/mL
  8. Potassium Canrenoate
    A8506 Potassium Canrenoate
    Target: Aldosterone receptor
    Summary: Aldosterone antagonist
      insoluble in EtOH; insoluble in DMSO; ≥117.4 mg/mL
  9. Nepicastat (SYN-117) HCl
    A4332 Nepicastat (SYN-117) HCl
    Summary: Dopamine-β-hydroxylase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥16.6 mg/mL
  10. A922500
    A4382 A922500
    Target: DGAT
    Summary: DGAT-1 inhibitor
      ≥21.25 mg/mL

Items 11-20 of 67

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 65item
  2. Lab Reagents 1 item
Reversibility
  1. Reversible 8item
  2. Irreversible 3item
Target
  1. Proteasome 3item
  2. Cathepsins 2item
  3. Histone Deacetylases (HDACs) 1 item
  4. CXCR 1 item
  5. Raf 1 item
  6. mTOR 1 item
  7. MMP 1 item
  8. GSK-3 1 item
  9. Factor Xa 1 item
  10. LPA Receptors 2item
  11. PLK 1 item
  12. VEGFR 1 item
  13. Bromodomain-containing proteins(BRDs) 1 item
  14. MEK 1 item
  15. CGRP receptors 1 item
  16. Smoothened 2item
  17. RARs 1 item
  18. ATP Citrate Lyases 1 item
  19. Microtubules/Tubulins 2item
  20. EGFR 3item
  21. ROCK 2item
  22. Progesterone Receptors 1 item
  23. CFTR 1 item
  24. ErbB 2item
  25. Calpains 1 item
  26. O-GlcNAcase 1 item
  27. Trypsins 1 item
  28. HER2 1 item
  29. DGAT 1 item
  30. Melanocortin (MC) Receptors 1 item
  31. RSK 1 item
  32. Free Fatty Acid Receptors 1 item
  33. CK2 1 item
  34. Melatonin Receptors 1 item
  35. P2X Receptors 1 item
  36. NPY Receptors 1 item
  37. Leukotriene and Related Receptors 1 item
  38. Histamine H1 Receptors 1 item
  39. Phospholipases 1 item
  40. HIV-1 reverse transcriptase 1 item
  41. Catechol O-Methyltransferase (COMT) 1 item
  42. Aldosterone receptor 1 item
  43. DPP-4 1 item
  44. DREADD Ligands 1 item
  45. ADAMs 1 item
  46. human lyase 1 item
  47. PPAR 1 item
  48. MSK 1 item
  49. FXR 1 item
  50. Substance P/NK1 Receptor 1 item
  51. MTH1 1 item
Related Disease
  1. Breast Cancer 12item
  2. Cancer 27item
  3. Colon Cancer 2item
  4. Colon Carcinoma 1 item
  5. Colorectal Cancer 3item
  6. Depression 1 item
  7. Diabetes 2item
  8. Glioma 1 item
  9. HIV Infections 2item
  10. Inflammatory Diseases 2item
  11. Lung Cancer 4item
  12. Mantle Cell Lymphoma 1 item
  13. Melanoma 3item
  14. Multiple Myeloma 4item
  15. Narcolepsy 1 item
  16. Neuroblastoma 1 item
  17. Non-small Cell Lung Cancer 2item
  18. Ovarian Cancer 3item
  19. Pancreatic Cancer 3item
  20. Prostate Cancer 3item
  21. Renal Cancer 1 item
  22. Renal Cell Carcinoma 1 item
  23. Sleep Disorders 2item
  24. Type 2 Diabetes 1 item